Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00577642 · BASELINE

Baseline characteristics

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates · Source last updated 2017-03-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      29
    units
    Participants
groups
  1. description
    Single dose Zoledronic Acid (Zoledronate) 4mg IV over at least 15 minutes (or dose corrected for creatinine clearance x1) followed by Aminobisphosphonates (aBP) cessation during study period
    id
    BG000
    title
    Zoledronic Acid
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          19
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          10
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          46
          upper Limit
          85
          value
          60
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          16
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          29
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Stage I
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Stage II
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Stage III
    description
    International Staging System (ISS) stage
    param Type
    NUMBER
    title
    ISS Stage
    unit Of Measure
    participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
      title
      Bortezomib + lenalidomide
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Bortezomib + Other
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Other
    param Type
    NUMBER
    title
    Therapy
    unit Of Measure
    participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      No
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Autologous Transplant
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      > 3 bone lesions
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      ≤ 3 bone lesions
    param Type
    NUMBER
    title
    Bone Lesions
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      29
    units
    Participants
groups
  1. description
    Single dose Zoledronic Acid (Zoledronate) 4mg IV over at least 15 minutes (or dose corrected for creatinine clearance x1) followed by Aminobisphosphonates (aBP) cessation during study period
    id
    BG000
    title
    Zoledronic Acid
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          19
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          10
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          46
          upper Limit
          85
          value
          60
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          16
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          29
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Stage I
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Stage II
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      Stage III
    description
    International Staging System (ISS) stage
    param Type
    NUMBER
    title
    ISS Stage
    unit Of Measure
    participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
      title
      Bortezomib + lenalidomide
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      Bortezomib + Other
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Other
    param Type
    NUMBER
    title
    Therapy
    unit Of Measure
    participants
  7. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      Yes
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      No
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Autologous Transplant
    unit Of Measure
    Participants
  8. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
      title
      > 3 bone lesions
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      ≤ 3 bone lesions
    param Type
    NUMBER
    title
    Bone Lesions
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice